BBP
Virtus Biotech ETF
1W: +5.9%
1M: -1.7%
3M: +3.2%
YTD: +4.2%
1Y: +37.8%
3Y: +73.7%
5Y: +63.4%
$83.63
-0.10 (-0.12%)
After Hours: $77.80 (-5.83, -6.97%)
Weekly Expected Move ±4.7%
$71
$75
$79
$82
$86
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$34M
Holdings63
Top 10 Wt26.9%
Beta1.06
% Profitable38%
Coverage99%
Portfolio Valuation
P/E28.9
P/B5.5
P/S6.4
EV/EBITDA17.6
P/FCF27.5
PEG2.14
Profitability & Returns
Gross Margin82.3%
Net Margin12.3%
ROE10.9%
ROA5.1%
ROIC12.0%
Div Yield0.10%
Leverage & Liquidity
Debt/Equity0.66
Debt/Assets0.31
Net Debt/EBITDA0.2x
Interest Cov5.2x
Current Ratio2.45
Quick Ratio2.13
Growth (YoY)
Revenue+59.7%
Net Income+49.0%
EPS+54.3%
FCF+47.2%
EBITDA+59.1%
Rev CAGR 3Y+103.8%
Quality Scores
Piotroski F5.0
Altman Z5.16
IS Quality54.2
IS Overall50.4
IS Value42.9
Median P/E-3.6
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 61 | 99.5% | -0.2 |
| Other | 3 | 0.5% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 64 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ImmunityBio Inc | IBRX | 5.01% | $2.6M | 357,747 | -20.6 | $7.5B | Healthcare |
| 2 | Day One Biopharmaceuticals Inc | DAWN | 4.10% | $2.2M | 100,990 | -20.7 | $2.2B | Healthcare |
| 3 | Moderna Inc | MRNA | 2.92% | $1.5M | 28,656 | -6.8 | $19.4B | Healthcare |
| 4 | Iovance Biotherapeutics Inc | IOVA | 2.69% | $1.4M | 383,763 | -3.6 | $1.1B | Healthcare |
| 5 | Mirum Pharmaceuticals Inc | MIRM | 2.19% | $1.2M | 12,987 | -202.3 | $4.7B | Healthcare |
| 6 | Novavax Inc | NVAX | 2.18% | $1.2M | 128,505 | 2.8 | $1.3B | Healthcare |
| 7 | BioCryst Pharmaceuticals Inc | BCRX | 2.03% | $1.1M | 111,529 | 7.2 | $1.9B | Healthcare |
| 8 | Roivant Sciences Ltd | ROIV | 1.98% | $1.0M | 38,202 | -24.4 | $20.3B | Healthcare |
| 9 | Syndax Pharmaceuticals Inc | SNDX | 1.94% | $1.0M | 41,445 | -7.6 | $2.2B | Healthcare |
| 10 | Geron Corp | GERN | 1.82% | $956,024 | 620,795 | -12.9 | $1.1B | Healthcare |
| 11 | Gilead Sciences Inc | GILD | 1.82% | $959,666 | 7,011 | 20.4 | $173.4B | Healthcare |
| 12 | KalVista Pharmaceuticals Inc | KALV | 1.80% | $946,117 | 49,927 | -6.0 | $1.0B | Healthcare |
| 13 | Kiniksa Pharmaceuticals International Plc | KNSA | 1.80% | $949,634 | 20,300 | 61.4 | $3.6B | Healthcare |
| 14 | Amgen Inc | AMGN | 1.78% | $937,640 | 2,655 | 24.3 | $187.6B | Healthcare |
| 15 | Axsome Therapeutics Inc | AXSM | 1.78% | $935,982 | 5,698 | -46.6 | $8.6B | Healthcare |
| 16 | Biogen Inc | BIIB | 1.76% | $926,259 | 4,848 | 20.1 | $26.0B | Healthcare |
| 17 | Agios Pharmaceuticals Inc | AGIO | 1.76% | $927,222 | 30,959 | -5.0 | $2.1B | Healthcare |
| 18 | United Therapeutics Corp | UTHR | 1.73% | $909,029 | 1,707 | 18.7 | $24.8B | Healthcare |
| 19 | Ligand Pharmaceuticals Inc | LGND | 1.72% | $907,054 | 4,453 | 31.6 | $4.0B | Healthcare |
| 20 | BioMarin Pharmaceutical Inc | BMRN | 1.67% | $879,690 | 15,836 | 30.5 | $10.7B | Healthcare |
| 21 | Exelixis Inc | EXEL | 1.66% | $874,776 | 20,651 | 15.2 | $11.8B | Healthcare |
| 22 | Krystal Biotech Inc | KRYS | 1.65% | $867,079 | 3,449 | 36.9 | $7.6B | Healthcare |
| 23 | Regeneron Pharmaceuticals Inc | REGN | 1.64% | $861,159 | 1,138 | 17.4 | $79.2B | Healthcare |
| 24 | TG Therapeutics Inc | TGTX | 1.64% | $861,221 | 26,930 | 10.7 | $5.4B | Healthcare |
| 25 | Halozyme Therapeutics Inc | HALO | 1.63% | $858,909 | 13,571 | 23.9 | $7.6B | Healthcare |
| 26 | Vertex Pharmaceuticals Inc | VRTX | 1.61% | $847,133 | 1,867 | 28.2 | $111.4B | Healthcare |
| 27 | Sarepta Therapeutics Inc | SRPT | 1.61% | $850,138 | 39,213 | -3.4 | $2.4B | Healthcare |
| 28 | Ascendis Pharma A/S | ASND | 1.60% | $844,898 | 3,830 | -53.6 | $14.1B | Healthcare |
| 29 | Zai Lab Ltd | ZLAB | 1.58% | $831,918 | 47,511 | -12.7 | $2.3B | Healthcare |
| 30 | Bridgebio Pharma Inc | BBIO | 1.55% | $815,364 | 11,234 | -19.8 | $14.2B | Healthcare |
| 31 | Incyte Corp | INCY | 1.55% | $816,316 | 8,848 | 14.7 | $19.1B | Healthcare |
| 32 | Aurinia Pharmaceuticals Inc | AUPH | 1.48% | $777,698 | 53,267 | 7.3 | $2.1B | Healthcare |
| 33 | BioNTech SE | BNTX | 1.48% | $778,744 | 8,904 | -16.7 | $22.9B | Healthcare |
| 34 | Ardelyx Inc | ARDX | 1.47% | $773,578 | 135,954 | -23.5 | $1.5B | Healthcare |
| 35 | Ionis Pharmaceuticals Inc | IONS | 1.47% | $775,437 | 10,445 | -31.8 | $12.4B | Healthcare |
| 36 | Madrigal Pharmaceuticals Inc | MDGL | 1.45% | $765,690 | 1,476 | -42.6 | $12.5B | Healthcare |
| 37 | PTC Therapeutics Inc | PTCT | 1.42% | $747,720 | 11,160 | 8.0 | $5.6B | Healthcare |
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 1.39% | $731,975 | 12,045 | 42.3 | $8.5B | Healthcare |
| 39 | Neurocrine Biosciences Inc | NBIX | 1.39% | $731,488 | 5,524 | 27.4 | $13.2B | Healthcare |
| 40 | BeOne Medicines Ltd | BGNE | 1.39% | $732,810 | 2,646 | 173.0 | $20.2B | Healthcare |
| 41 | CRISPR Therapeutics AG | CRSP | 1.35% | $708,210 | 14,894 | -7.7 | $4.8B | Healthcare |
| 42 | Theravance Biopharma Inc | TBPH | 1.34% | $705,788 | 46,464 | 7.7 | $825M | Healthcare |
| 43 | Immunocore Holdings PLC | IMCR | 1.33% | $699,899 | 22,940 | -58.0 | $1.6B | Healthcare |
| 44 | Tarsus Pharmaceuticals Inc | TARS | 1.32% | $697,402 | 10,378 | -45.2 | $3.0B | Healthcare |
| 45 | Alnylam Pharmaceuticals Inc | ALNY | 1.32% | $696,356 | 2,122 | 134.4 | $42.3B | Healthcare |
| 46 | Kura Oncology Inc | KURA | 1.31% | $690,620 | 82,610 | -2.7 | $761M | Healthcare |
| 47 | Travere Therapeutics Inc | TVTX | 1.29% | $676,753 | 24,239 | -54.7 | $2.8B | Healthcare |
| 48 | ACADIA Pharmaceuticals Inc | ACAD | 1.27% | $667,610 | 31,095 | 9.6 | $3.8B | Healthcare |
| 49 | Legend Biotech Corp | LEGN | 1.26% | $661,542 | 37,824 | -11.9 | $3.5B | Healthcare |
| 50 | Arcutis Biotherapeutics Inc | ARQT | 1.24% | $651,079 | 29,092 | -187.8 | $2.9B | Healthcare |